Unboosted versus boosted atazanavir for reducing morbidity and mortality in people with HIV/AIDS

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine whether unboosted atazanavir‐containing regimens are more effective and safe than boosted atazanavir‐containing regimens in reducing morbidity and mortality in people living with HIV/AIDS.

Uloženo v:
Podrobná bibliografie
Vydáno v:Cochrane Database Syst Rev
Hlavní autoři: Cohen, Karen, Kredo, Tamara, de Waal, Renee
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd 2018
Témata:
Medicine General & Introductory Medical Sciences
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6491095/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005418.pub3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky